Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Real-world assessment of treatment sequencing of patients with advanced biliary tract cancer in a private practice in Rio de Janeiro and São Paulo, Brazil.
Authors
Ligia Carvalho
Americas Centro de Oncologia Integrado, Rio De Janeiro, Brazil;
Ligia Carvalho , Kaique Ferreira Costa de Almeida , Lais Saldanha , Kelly de Paula Beck , Ana Paula Victorino
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 587)
DOI
10.1200/JCO.2023.41.4_suppl.587
Abstract #
587
Poster Bd #
E19
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
A single arm, prospective multicenter phase II study FOLFIRINOX in patients with advanced and recurrent biliary tract cancer.
First Author: Naminatsu Takahara
Poster
2014 Gastrointestinal Cancers Symposium
Second-line FOLFOX chemotherapy in patients with metastatic gallbladder cancer and cholangiocarcinoma.
First Author: Jose Luis Leal
Poster
2021 ASCO Annual Meeting
Clinical outcomes analysis of TP53-mutated advanced and metastatic biliary tract cancers.
First Author: Sunyoung S. Lee
Poster
2021 ASCO Annual Meeting
Association of cell-free DNA dominant clone allele frequency with poor outcomes in advanced biliary cancers treated with platinum-based chemotherapy.
First Author: Umair Majeed